| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10594202 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
A novel methodology for the selection of a representative primary and secondary screening panel of rhinoviral serotypes for the purposes of identifying potential antiviral agents is presented. This methodology focuses on the active-sites of the rhinoviral proteins but does not invoke historical SAR data, thereby avoiding compound bias.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Nick Tomkinson, Mark Wenlock, Christopher McCrae,